ARCHIVES

Patient Advocacy: FDA, NCI Developing Methods For Naming Survivors To Boards

This article is from The Cancer Letter archive.

Vol. 23 No. 05 | February 7, 1997

Download PDF Visit The Full Archive

Related Articles

Complaints Are “Astonishingly Far From Facts,” But NCI May Be Leaving Good Science Unfunded

April 29, 1977

Breast Cancer Overview Correlates Incidence Increase With Other Factors

July 29, 1988

Imbruvica Improves PFS, OS In Phase III CLL Study

December 26, 2014

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994

Alimta/Cisplatin Chemotherapy Increased Overall Survival

June 29, 2012

Improvements Still Needed To Reduce Chemo Errors

November 25, 2005